Literature DB >> 34017079

Yorkie-Cactus (IκBα)-JNK axis promotes tumor growth and progression in Drosophila.

Kirti Snigdha1, Amit Singh1,2,3,4, Madhuri Kango-Singh5,6,7,8.   

Abstract

Presence of inflammatory factors in the tumor microenvironment is well-documented yet their specific role in tumorigenesis is elusive. The core inflammatory pathways like the Toll-Like Receptor (TLR) and the Tumor Necrosis Factor (TNF) pathway are conserved in Drosophila. We induced GFP-marked epithelial tumors by expressing activated oncogenic forms of RasV12 or Yorkie (Yki3SA, mammalian YAP) in scribble deficient cells (scribRNAi, mammalian SCRIB) to study the role of inflammatory factors in tumorigenesis. Similar to RasV12scribRNAi, we found that Yki3SAscribRNAi form invasive neoplastic lethal tumors that induce a systemic inflammatory response. We identified Cactus (Cact, mammalian IκBα), the negative regulator of TLR, as a key player in tumor growth. Cact accumulates in the cytoplasm in Drosophila tumor models, similar to squamous cell carcinoma in mice models and human patients where cytoplasmic IκBα favors oncogenic transformation. Further, cact is transcriptionally upregulated in tumors, and downregulation of Cact affects tumor growth. We investigated if TLR or TNF pathway affect tumor growth through activation of Jun N-terminal Kinase (JNK) pathway and its target Matrix Metalloprotease1 (MMP1). Genetically manipulating levels of TLR components or TNF receptors showed that Cact acts upstream of JNK signaling and regulates JNK via a non-canonical mechanism during tumorigenesis. Further, Hippo coactivator Yki transcriptionally regulates cact expression, and downregulation of Yki or Cact is sufficient to cause downregulation of JNK-mediated signaling that promotes tumorigenesis. Here, we report a link between Hippo, IκBα and JNK signaling that may induce inflammation and innate immune response in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34017079     DOI: 10.1038/s41388-021-01831-4

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   8.756


  75 in total

Review 1.  The immune response of Drosophila.

Authors:  Jules A Hoffmann
Journal:  Nature       Date:  2003-11-06       Impact factor: 49.962

2.  Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation.

Authors:  Cristina Cellurale; Guadalupe Sabio; Norman J Kennedy; Madhumita Das; Marissa Barlow; Peter Sandy; Tyler Jacks; Roger J Davis
Journal:  Mol Cell Biol       Date:  2011-01-31       Impact factor: 4.272

Review 3.  Evolution and integration of innate immune systems from fruit flies to man: lessons and questions.

Authors:  Cosimo Martinelli; Jean-Marc Reichhart
Journal:  J Endotoxin Res       Date:  2005

Review 4.  Inflammation meets cancer, with NF-κB as the matchmaker.

Authors:  Yinon Ben-Neriah; Michael Karin
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

5.  Ras in cancer and developmental diseases.

Authors:  Alberto Fernández-Medarde; Eugenio Santos
Journal:  Genes Cancer       Date:  2011-03

Review 6.  Cancer-related inflammation.

Authors:  Alberto Mantovani; Paola Allavena; Antonio Sica; Frances Balkwill
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

Review 7.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

Review 8.  YAP/TAZ at the Roots of Cancer.

Authors:  Francesca Zanconato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Cancer Cell       Date:  2016-06-13       Impact factor: 31.743

9.  Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover.

Authors:  Xin Hong; Hung Thanh Nguyen; Qingfeng Chen; Rui Zhang; Zandra Hagman; P Mathijs Voorhoeve; Stephen M Cohen
Journal:  EMBO J       Date:  2014-09-01       Impact factor: 11.598

Review 10.  Two-Faced: Roles of JNK Signalling During Tumourigenesis in the Drosophila Model.

Authors:  John E La Marca; Helena E Richardson
Journal:  Front Cell Dev Biol       Date:  2020-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.